• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多重耐药和广泛耐药结核病时代的临床挑战

Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis.

作者信息

Laniado-Laborín Rafael

机构信息

Facultad de Psicología y Medicina Universidad Autónoma de Baja California TijuanaBaja California Mexico Facultad de Psicología y Medicina, Universidad Autónoma de Baja California, Tijuana, Baja California, Mexico.

出版信息

Rev Panam Salud Publica. 2017 Dec 26;41:e167. doi: 10.26633/RPSP.2017.167. eCollection 2017.

DOI:10.26633/RPSP.2017.167
PMID:31384279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6650628/
Abstract

. . . .

摘要

. . . .

相似文献

1
Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis.多重耐药和广泛耐药结核病时代的临床挑战
Rev Panam Salud Publica. 2017 Dec 26;41:e167. doi: 10.26633/RPSP.2017.167. eCollection 2017.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发：现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.西太平洋地区抗击结核病流行：现状与未来挑战
Kekkaku. 2010 Jan;85(1):9-16.
4
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.抗击广泛耐药结核病计划：联邦结核病特别工作组的建议
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
5
Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.耐多药结核病和广泛耐药结核病的管理：现状与未来展望
Kekkaku. 2011 Jan;86(1):9-16.
6
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南：肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
7
Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.耐多药和广泛耐药结核病（M/XDR-TB）：问题与解决方案
Indian J Tuberc. 2010 Oct;57(4):180-91.
8
Drug-resistant tuberculosis: past, present, future.耐药结核病：过去、现在和未来。
Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19.
9
Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.预防耐多药结核病的传播和保护传染病接触者。
Clin Microbiol Infect. 2017 Mar;23(3):147-153. doi: 10.1016/j.cmi.2016.08.024. Epub 2016 Aug 31.
10
Overview of drug-resistant tuberculosis worldwide.全球耐药结核病概述。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S161. doi: 10.1016/j.ijmyco.2016.09.066. Epub 2016 Nov 11.

引用本文的文献

1
evaluation of snake venom proteins against multidrug-resistant : A molecular dynamics study and simulation dynamic.针对多重耐药性的蛇毒蛋白评估：一项分子动力学研究与动态模拟
Open Vet J. 2025 Feb;15(2):774-784. doi: 10.5455/OVJ.2025.v15.i2.26. Epub 2025 Feb 28.
2
The association of IL-17A rs2275913 single nucleotide polymorphism with anti-tuberculous drug resistance in patients with pulmonary tuberculosis.白细胞介素-17A基因rs2275913单核苷酸多态性与肺结核患者抗结核药物耐药性的关联
J Genet Eng Biotechnol. 2023 Sep 4;21(1):90. doi: 10.1186/s43141-023-00542-5.
3
Recent Discoveries of Nitrogen-Containing Heterocyclic Compounds as InhA Inhibitors against : An Overview.含氮杂环化合物作为InhA抑制剂的最新发现概述
Infect Disord Drug Targets. 2022;22(8):19-29. doi: 10.2174/1871526522666220420092618.

本文引用的文献

1
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials.耐多药结核病的短程治疗：STREAM试验
Eur Respir Rev. 2016 Mar;25(139):29-35. doi: 10.1183/16000617.0080-2015.
2
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.控制结核病的源头：结核感染的诊断与治疗
Lancet. 2015 Dec 5;386(10010):2344-53. doi: 10.1016/S0140-6736(15)00323-2. Epub 2015 Oct 26.
3
Developments in Impact Assessment of New Diagnostic Algorithms for Tuberculosis Control.发展新型结核病控制诊断算法的影响评估。
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S126-34. doi: 10.1093/cid/civ580.
4
Drug-resistance--a challenge for tuberculosis control in the European Union and European Economic Area.耐药性——欧盟和欧洲经济区结核病控制面临的一项挑战。
Euro Surveill. 2014 Mar 20;19(11):20737. doi: 10.2807/1560-7917.es2014.19.11.20737.
5
Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis.用于结核分枝杆菌快速药敏试验的全基因组测序
N Engl J Med. 2013 Jul 18;369(3):290-2. doi: 10.1056/NEJMc1215305.
6
Tuberculosis: are we making it incurable?结核病：我们正在使其变得无法治愈吗？
Eur Respir J. 2013 Jul;42(1):5-8. doi: 10.1183/09031936.00206712.
7
Totally drug-resistant tuberculosis (TDR-TB) in India: every dark cloud has a silver lining.印度的完全耐药结核病（TDR-TB）：黑暗中总有一线光明。
J Epidemiol Community Health. 2013 Jun;67(6):471-2. doi: 10.1136/jech-2012-201640. Epub 2012 Nov 15.
8
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.耐多药结核病之外的耐药性：个体患者数据荟萃分析。
Eur Respir J. 2013 Jul;42(1):169-179. doi: 10.1183/09031936.00136312. Epub 2012 Oct 11.
9
Totally drug-resistant tuberculosis in India: who let the djinn out?印度的完全耐药结核病：究竟是谁放出了这头“恶魔”？
Respirology. 2012 Jul;17(5):741-2. doi: 10.1111/j.1440-1843.2012.02192.x.
10
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.耐药结核病——当前的困境、未解答的问题、挑战和优先需求。
J Infect Dis. 2012 May 15;205 Suppl 2:S228-40. doi: 10.1093/infdis/jir858. Epub 2012 Apr 3.